Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Sep 20;42(9):1335-1343.
doi: 10.12122/j.issn.1673-4254.2022.09.09.

[microRNA let-7g-3p regulates proliferation, migration, invasion and apoptosis of bladder cancer cells by targeting HMGB2]

[Article in Chinese]
Affiliations

[microRNA let-7g-3p regulates proliferation, migration, invasion and apoptosis of bladder cancer cells by targeting HMGB2]

[Article in Chinese]
Z Zou et al. Nan Fang Yi Ke Da Xue Xue Bao. .

Abstract

Objective: To explore the molecular mechanism by which microRNA let-7g-3p regulates biological behaviors of bladder cancer cells.

Methods: The expression levels of let-7g-3p in bladder cancer and adjacent tissues, normal bladder epithelial cells (HUC cells) and bladder cancer cells (T24, 5637 and EJ cells) were detected using qRT- PCR. T24 cells were transfected with let-7g-3p mimic or inhibitor, and the changes in cell proliferation, migration, invasion, and apoptosis were examined. Transcriptome sequencing was carried out in cells overexpressing let-7g-3p, and the results of bioinformatics analysis, double luciferase reporter gene assay, qRT-PCR and Western blotting confirmed that HMGB2 gene was the target gene of let-7g-3p. The expression of HMGB2 was examined in HUC, T24, 5637 and EJ cells, and in cells with HMGB2 knockdown, the effect of let-7g-3p knockdown on the biological behaviors were observed.

Results: qRT-qPCR confirmed that let-7g-3p expression was significantly lower in bladder cancer tissues and cells (P < 0.01). Overexpression of let-7g-3p inhibited cell proliferation, migration and invasion, and promoted cell apoptosis, while let-7g-3p knock-down produced the opposite effects. Bioinformatics and transcriptome sequencing results showed that HMGB2 was the key molecule that mediate the effect of let-7g-3p on bladder cancer cells. Luciferase reporter gene assay, qRT-PCR and Western blotting all confirmed that HMGB2 was negatively regulated by let-7g-3p (P < 0.01). Knocking down HMGB2 could partially reverse the effect of let-7g-3p knockdown on the biological behaviors of the bladder cancer cells.

Conclusion: The microRNA let-7g-3p can inhibit the biological behavior of bladder cancer cells by negatively regulating HMGB2 gene.

目的: 探讨MiR-let-7g-3p靶向HMGB2对膀胱癌细胞生物学行为的影响及其分子机制。

方法: 通过qRT-PCR检测膀胱癌组织和癌旁组织以及正常尿路上皮细胞SV-HUC-1和膀胱癌细胞(T24、5637和EJ)中let-7g-3p的表达水平;通过转染过表达或敲低T24细胞let-7g-3p表达,检测细胞增殖、迁移和侵袭、和凋亡等变化;对过表达let-7g-3p的细胞进行转录组测序,结合生物信息学分析,通过双荧光素酶报告实验、qRT-PCR和Western-blot分析let-7g-3p靶向负性调控HMGB2基因;qRT-PCR检测正常尿路上细胞和膀胱癌细胞(T24、5637和EJ)中HMGB2的表达水平,并且在敲低HMGB2的细胞株中,敲低let-7g-3p,检测细胞生物学行为改变。

结果: qRT-qPCR证实let-7g-3p在膀胱癌组织和细胞表达明显下调(P < 0.01);过表达let-7g-3p可抑制细胞增殖、迁移和侵袭,促进细胞凋亡(P < 0.01);相反,敲减let-7g-3p表达可促进细胞增殖、迁移和侵袭,抑制细胞凋亡(P < 0.01)。生物信息学和转录组测序结果显示,HMGB2是let-7g-3p作用于膀胱癌细胞的关键分子;双荧光素酶报告实验、qRT-PCR和Western blot显示,HMGB2受let-7g-3p的负性调控;HMGB2膀胱癌细胞中表达水平均明显上调(P < 0.01),敲低HMGB2可部分逆转敲低let-7g-3p对膀胱癌细胞生长的促进作用。

结论: MiRNA-let-7g-3p通过靶向负性调控HMGB2基因抑制膀胱癌细胞的生物行为。

Keywords: HMGB2; bladder cancer; let-7g-3p.

PubMed Disclaimer

Figures

图 1
图 1
let-7g-3p在膀胱癌组织中的表达水平 Expression level of let-7g-3p in bladder cancer tissues (n=5, **P < 0.01).
图 2
图 2
let-7g-3p在膀胱癌细胞中的表达水平 Expression level of let-7g-3p in bladder cancer cells lines (n=3). **P < 0.01 vs SV-HUC-1.
图 3
图 3
let-7g-3p和HMGB2转染效率的验证 Expression of let-7g-3p and HMGB2 in bladder cancer cells. A: let-7g-3p was successfully knocked down or over-expressed in bladder cancer cells. B: HMGB2 was successfully knocked down in bladder cancer cells. **P < 0.01 (n=3).
图 4
图 4
let-7g-3p对膀胱癌细胞增殖、迁移、侵袭及凋亡的影响 Effects of let-7g-3p on proliferation, migration, invasion and apoptosis of bladder cancer cells. A, B: CCK8 assay for assessing the proliferation ability of T24 cells with let-7g-3p knockdown or overexpression. C, D: Transwell assay for assessing migration and invasion ability of T24 cells with let-7g-3p knockdown or overexpression (Original magnification: ×100). E: Flow cytometry for assessing apoptosis of T24 cells with let-7g-3p knockdown or overexpression. **P < 0.01 vs NC (n=3).
图 5
图 5
let-7g-3p与HMGB2的靶向关系 Targeting relationship between let-7g-3p and HMGB2. A: Result of transcriptome sequencing. B: Wayne diagram of the major databases. C: Expression level of HMGB2 in each group of samples in the results of transcriptome sequencing. D: Binding site between let-7g-3p and HMGB2.
图 6
图 6
双荧光素酶报告实验的结果 Results of the double luciferase reporter gene assay (n=3, **P < 0.01).
图 7
图 7
过表达let-7g-3p可以显著降低HMGB2的表达水平 Overexpression of let-7g-3p significantly reduces the expression level of HMGB2. A: Overexpression of let-7g-3p reduces the mRNA expression level of HMGB2 detected by qRT-PCR. B, C: Overexpression of let-7g-3p reduces protein expression level of HMGB2 detected by Western blotting. D: Overexpression of HMGB2 does not affect the expression level of let-7g-3p detected by qRT-PCR. **P < 0.01, ***P < 0.001 (n=3).
图 8
图 8
HMGB2在膀胱癌细胞中的表达水平 Expression level of HMGB2 in bladder cancer cells. **P < 0.01 vs SV-HUC-1 (n=3).
图 9
图 9
let-7g-3p靶向HMGB2调控膀胱癌细胞增殖、迁移、侵袭及凋亡 let-7g-3p targets HMGB2 to regulate the proliferation, migration, invasion and apoptosis of bladder cancer cells. A: Knockdown of HMGB2 partially reverses the effect of let-7g-3p knockdown on migration and invasion of T24 cells. B, C: Knock-down of HMGB2 partially reverses the effect of let-7g-3p knockdown on proliferation of T24 cells (×100). D: Knock-down of HMGB2 partially reverses the effect of let-7g-3p knockdown on apoptosis of T24 cells. **P < 0.01 (n=3)
图 10
图 10
GO和KEGG通路富集分析的结果 Enrichment analysis of GO and KEGG pathways. A: Histogram of GO enrichment analysis. B: Bubble diagram of KEGG pathways enrichment analysis.

Similar articles

Cited by

References

    1. Pugashetti N, Alibhai SMH, Yap SA. Non-muscle-invasive bladder cancer: review of diagnosis and management. J Curr Clin Care. 2015;105:540–50.
    1. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2016. CA A Cancer J Clin. 2016;66(1):7–30. doi: 10.3322/caac.21332. - DOI - PubMed
    1. Kamat AM, Hahn NM, Efstathiou JA, et al. Bladder cancer. Lancet. 2016;388(10061):2796–810. doi: 10.1016/S0140-6736(16)30512-8. - DOI - PubMed
    1. Hill M, Tran N. miRNA interplay: mechanisms and consequences in cancer. Dis Model Mech. 2021;14(4):047662–71. - PMC - PubMed
    1. Wang H, Ke C, Ma X, et al. microRNA-92 promotes invasion and chemoresistance by targeting GSK3β and activating Wnt signaling in bladder cancer cells. Tumour Biol. 2016;2016(9):517–25. - PubMed